Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
José Daniel
José Daniel Altamirano, Concepcion AR
| Patent application number | Description | Published |
|---|---|---|
| 20110230869 | SURGICAL INSTRUMENT EQUIPMENT APPROPRIATE FOR MINI-INVASIVE SURGERY - Equipment of surgical instruments suitable for minimally invasive surgery, comprised by a multivalve device with adjustable separator to enter the patient's body and with at least one access simultaneous port for a number of components which includes an operative surgical device comprised by a control, a movement transmission element and an operative mounting clamp of a needle plier comprised by a control, a head connecting sheath, with a connecting needle lodged in its interior and the operative head; and a cauterization device comprised by a control, a movement transmitting element and the cautery. | 09-22-2011 |
José Daniel Aroca Aguilar, Ciudad Real ES
| Patent application number | Description | Published |
|---|---|---|
| 20100047212 | USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal. | 02-25-2010 |
José Daniel Aroca Aguilar, Ciudad Real ES
| Patent application number | Description | Published |
|---|---|---|
| 20100047212 | USE OF THE PEDF FACTOR TO INDUCE CELL REGENERATION - Use of the PEDF factor to induce cell regeneration. The present invention refers to the use of the molecule PEDF for the manufacture of medicines to activate processes included in the group of regenerative processes, such as skin regeneration, wound healing, cell therapy for cardiac, neural, or hematopoietic regeneration. It also refers to the manufacture/use of pharmaceutical compounds that contain an efficient quantity of the PEDF factor for stem cell self-renewal. | 02-25-2010 |